1. Home
  2. TECX vs CIVB Comparison

TECX vs CIVB Comparison

Compare TECX & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$19.69

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo Civista Bancshares Inc.

CIVB

Civista Bancshares Inc.

N/A

Current Price

$28.13

Market Cap

571.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
CIVB
Founded
2019
1884
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
571.6M
IPO Year
2018
2012

Fundamental Metrics

Financial Performance
Metric
TECX
CIVB
Price
$19.69
$28.13
Analyst Decision
Strong Buy
Buy
Analyst Count
10
6
Target Price
★ $71.00
$31.33
AVG Volume (30 Days)
★ 182.1K
98.7K
Earning Date
11-13-2026
10-22-2026
Dividend Yield
N/A
★ 2.53%
EPS Growth
★ 40.70
31.34
EPS
N/A
★ 1.41
Revenue
N/A
★ $19,023,000.00
Revenue This Year
N/A
$11.01
Revenue Next Year
N/A
$3.80
P/E Ratio
★ N/A
$20.20
Revenue Growth
★ N/A
N/A
52 Week Low
$15.60
$21.10
52 Week High
$39.53
$29.97

Technical Indicators

Market Signals
Indicator
TECX
CIVB
Relative Strength Index (RSI) 30.40 60.79
Support Level $16.77 $27.97
Resistance Level $22.44 $29.53
Average True Range (ATR) 1.08 0.62
MACD 0.16 0.17
Stochastic Oscillator 4.51 69.96

Price Performance

Historical Comparison
TECX
CIVB

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.

Share on Social Networks: